Effect of Protein-Restricted Diet on Nitrogen Balance and Residual Renal Function in Peritoneal Dialysis (PD) Patients

NCT ID: NCT00633646

Last Updated: 2008-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current therapy recommendations suggest a low protein diet to preserve residual renal function (RRF) before the start of dialysis, but a higher protein intake during dialysis to prevent protein-energy wasting (PEW). We conducted a randomized trial to test whether low protein intake also during treatment with peritoneal dialysis (PD) would be safe and associated with a preserved RRF.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dietary protein is the major source of nitrogen excreted as urea by the kidney, and a decreased protein intake has been associated with a retardation of kidney function loss in non-dialysis chronic kidney disease (CKD) patients. While a low protein diet is recommended to end-stage renal disease (ESRD) patients before the start of dialysis to preserve residual renal function(RRF), current therapy recommendations in dialysis are for a normal protein intake of no less than 1.2 g of protein/kg ideal body weight (IBW)/day to prevent protein-energy wasting (PEW).

We hypothesized that a lower protein intake would be safe and able to slow the loss of RRF also in dialysis patients and conducted two prospective, randomized trials involving a total of 94 peritoneal dialysis (PD) patients to test our hypothesis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease Peritoneal Dialysis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

nitrogen balance malnutrition chronic kidney disease diet glomerular filtration rate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

low protein diet

Group Type ACTIVE_COMPARATOR

diets contained different levels of protein

Intervention Type DIETARY_SUPPLEMENT

diets contain protein in the range of 0.6-0.8 or 1.0-1.2 g/kg/d

2

low protein diet with keto acids

Group Type ACTIVE_COMPARATOR

diets contained different levels of protein

Intervention Type DIETARY_SUPPLEMENT

diets contain protein in the range of 0.6-0.8 or 1.0-1.2 g/kg/d

3

high protein diet

Group Type ACTIVE_COMPARATOR

diets contained different levels of protein

Intervention Type DIETARY_SUPPLEMENT

diets contain protein in the range of 0.6-0.8 or 1.0-1.2 g/kg/d

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diets contained different levels of protein

diets contain protein in the range of 0.6-0.8 or 1.0-1.2 g/kg/d

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

LP sLP HP

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-80 years
* stable peritoneal dialysis since at least 1 month
* with renal function

Exclusion Criteria

* a high probability (assessed by the recruiting physician) of receiving a kidney transplant within one year
* overt infection within the last month
* poor compliance in previous dietary prescriptions or irregular check-ups
* persistent anorexia, vomiting or diarrhea within the last month
* a CRP of more than 30 mg/dL
* presence of wasting diseases such as cancer or tuberculosis
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Renji Hospital, Shanghai Jiaotong University, School of Medicine

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yao Qiang, MD, Ph.D

Role: PRINCIPAL_INVESTIGATOR

RenJi Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

05PJ14057(Shanghai, China)

Identifier Type: -

Identifier Source: org_study_id